📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The novel mitochondria-targeted hydrogen sulfide (H2S) donors AP123 and AP39 protect against hyperglycemic injury in microvascular endothelial cells in vitro. (2016)

First Author: Gero D

Attributed to: Precision Medicine Exeter Innovation Platform (PMEI Platform): Proof of Concept Funds funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.phrs.2016.08.019

PubMed Identifier: 27565382

Publication URI: http://europepmc.org/abstract/MED/27565382

Type: Journal Article/Review

Volume: 113

Parent Publication: Pharmacological research

Issue: Pt A

ISSN: 1043-6618